Kennedy Capital Management LLC Sells 542 Shares of Chemed Co. (NYSE:CHE)

Kennedy Capital Management LLC lessened its position in shares of Chemed Co. (NYSE:CHE) by 2.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 24,723 shares of the company’s stock after selling 542 shares during the quarter. Kennedy Capital Management LLC owned about 0.16% of Chemed worth $13,098,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in CHE. UMB Bank n.a. grew its stake in Chemed by 300.0% in the fourth quarter. UMB Bank n.a. now owns 52 shares of the company’s stock valued at $28,000 after purchasing an additional 39 shares in the last quarter. Atala Financial Inc acquired a new stake in Chemed during the 4th quarter worth approximately $29,000. CBIZ Investment Advisory Services LLC increased its stake in Chemed by 64.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock worth $30,000 after acquiring an additional 22 shares during the period. Trust Co. of Vermont bought a new position in Chemed during the 4th quarter worth $34,000. Finally, Tortoise Investment Management LLC grew its position in Chemed by 77.3% during the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company’s stock worth $41,000 after acquiring an additional 34 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

CHE has been the subject of several recent analyst reports. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Royal Bank of Canada boosted their price target on Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research report on Friday, March 14th.

Chemed Price Performance

Chemed stock opened at $587.42 on Thursday. The firm has a market capitalization of $8.60 billion, a P/E ratio of 29.68, a price-to-earnings-growth ratio of 2.15 and a beta of 0.49. The company’s 50-day moving average is $581.75 and its 200 day moving average is $567.98. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $627.12.

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were issued a $0.50 dividend. The ex-dividend date was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. Chemed’s payout ratio is 10.05%.

Insider Buying and Selling

In other news, CEO Kevin J. Mcnamara sold 1,000 shares of Chemed stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $615.33, for a total transaction of $615,330.00. Following the sale, the chief executive officer now owns 101,679 shares in the company, valued at approximately $62,566,139.07. The trade was a 0.97 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 3.32% of the stock is currently owned by company insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.